StonvexLoading…
StonvexStonvexStonvexCore line items from DHT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $498.40M | $571.77M | $560.56M | $454.15M |
Operating Income | $224.97M | $210.64M | $193.11M | $74.20M |
Net Income | $210.96M | $181.46M | $161.40M | $61.98M |
EPS (Diluted) | $1.31 | $1.12 | $0.99 | $0.37 |
Total Assets | $1.60B | $1.49B | $1.49B | $1.51B |
Total Liabilities | $469.69M | $443.89M | $460.56M | $434.99M |
Cash & Equivalents | $79.03M | $78.14M | $74.74M | $125.95M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | Not available | Not available | Not available |